Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance Journal Article


Authors: Zhan, W.; Li, D.; Subramanyaswamy, S. B.; Liu, Y. J.; Yang, C.; Zhang, H.; Harris, J. C.; Wang, R.; Zhu, S.; Rocha, H.; Sherman, J.; Qin, J.; Herring, M.; Simwela, N. V.; Waters, A. P.; Sukenick, G.; Cui, L.; Rodriguez, A.; Deng, H.; Nathan, C. F.; Kirkman, L. A.; Lin, G.
Article Title: Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance
Abstract: Artemisinins (ART) are critical anti-malarials and despite their use in combination therapy, ART-resistant Plasmodium falciparum is spreading globally. To counter ART resistance, we designed artezomibs (ATZs), molecules that link an ART with a proteasome inhibitor (PI) via a non-labile amide bond and hijack parasite's own ubiquitin-proteasome system to create novel anti-malarials in situ. Upon activation of the ART moiety, ATZs covalently attach to and damage multiple parasite proteins, marking them for proteasomal degradation. When damaged proteins enter the proteasome, their attached PIs inhibit protease function, potentiating the parasiticidal action of ART and overcoming ART resistance. Binding of the PI moiety to the proteasome active site is enhanced by distal interactions of the extended attached peptides, providing a mechanism to overcome PI resistance. ATZs have an extra mode of action beyond that of each component, thereby overcoming resistance to both components, while avoiding transient monotherapy seen when individual agents have disparate pharmacokinetic profiles. © 2023 Elsevier Ltd
Keywords: ubiquitin; animal; metabolism; animals; proteasome; proteasome inhibitor; proteasome endopeptidase complex; drug resistance; chemistry; pharmacophore; antimalarial agent; antimalarials; malaria; hybrid; plasmodium; parasite; parasites; artemisinin; artemisinin resistance; dual-resistance; in vivo efficacy; mouse models of malaria infection; recrudescence; artemisinin derivative; artemisinins
Journal Title: Cell Chemical Biology
Volume: 30
Issue: 5
ISSN: 2451-9456
Publisher: Cell Press  
Date Published: 2023-05-18
Start Page: 457
End Page: 469.e11
Language: English
DOI: 10.1016/j.chembiol.2023.04.006
PUBMED: 37148884
PROVIDER: scopus
PMCID: PMC10240386
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rong Wang
    8 Wang